Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.
Vasc Health Risk Manag. 2017;13:293-303
Clin Lymphoma Myeloma Leuk. 2017 Jul 15;:
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
J Cardiovasc Magn Reson. 2017 Aug 07;19(1):61
High-risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure.
J Thorac Cardiovasc Surg. 2017 Mar 21;:
Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial.
Eur J Heart Fail. 2017 Apr;19(4):579-587
Cardiologist's perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.
Leukemia. 2016 Dec 02;:
A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac Support.
Am J Cardiol. 2016 Aug 23;
JAMA Cardiol. 2016 Jun 22;
Human leukocyte antigen G single-nucleotide polymorphism -201 (CC-CC) donor-recipient genotype matching as a predictor of severe cardiac allograft vasculopathy.
J Heart Lung Transplant. 2016 May 6;
J Card Fail. 2016 Feb 1;